سعر ستيميولان 200مجم/مل شراب 120 مل 2024

Piracetam 200 mg/ml oral syrup, 120 ml bottle, by Amoun (Egypt); a pyrrolidone-derivative nootropic.

• UK-licensed indication (tablets): adult patients with myoclonus of cortical origin, irrespective of aetiology, in combination with other anti-myoclonic therapies.Population: Adultselectronic medicines compendium (eMC)

• Common: nervousness, hyperkinesia, weight increased. Uncommon: depression, somnolence, asthenia. Not known: haemorrhagic disorder, anaphylactoid reaction/hypersensitivity, agitation, anxiety, confusion, hallucination, ataxia, balance impaired, epilepsy aggravated, headache, insomnia, vertigo, abdominal pain, diarrhoea, nausea, vomiting, angioneurotic oedema, dermatitis, pruritus, urticaria.General active-ingredient information · electronic medicines compendium (eMC)

• Hypersensitivity to piracetam or other pyrrolidone derivatives; severe renal impairment (creatinine clearance below 20 ml/min); cerebral haemorrhage; Huntington's chorea.General active-ingredient information · electronic medicines compendium (eMC)

• Effect on platelet aggregation: caution in severe haemorrhage, bleeding risk (e.g. gastrointestinal ulcer), haemostasis disorders, history of haemorrhagic stroke, major or dental surgery, and with anticoagulants or antiplatelet drugs including low-dose aspirin.General active-ingredient information · electronic medicines compendium (eMC)
• Eliminated by the kidneys: care in renal insufficiency; regular creatinine clearance evaluation in long-term treatment of the elderly; avoid abrupt discontinuation (may induce myoclonic or generalised seizures in myoclonic patients).General active-ingredient information · electronic medicines compendium (eMC)

• Thyroid hormones (thyroid extract T3 + T4)Confusion, irritability and sleep disorder reported during concomitant treatment.electronic medicines compendium (eMC)
• Acenocoumarol / anticoagulantsPiracetam 9.6 g/day did not change acenocoumarol dose needs but further decreased platelet aggregation, fibrinogen, von Willebrand factors and blood viscosity; caution with anticoagulants and antiplatelet drugs.electronic medicines compendium (eMC)

• Piracetam crosses the placenta; newborn drug levels are about 70-90% of maternal levels. Do not use in pregnancy unless clearly necessary, when benefit exceeds risk. No teratogenic effects in mice, rats or rabbits at high doses.General active-ingredient information · electronic medicines compendium (eMC)
• Excreted in human breast milk; do not use while breastfeeding, or discontinue breastfeeding during treatment.General active-ingredient information · electronic medicines compendium (eMC)